{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T20:05:15Z","timestamp":1770753915256,"version":"3.50.0"},"reference-count":26,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2020,3]]},"DOI":"10.1016\/j.ejphar.2019.172849","type":"journal-article","created":{"date-parts":[[2019,12,13]],"date-time":"2019-12-13T03:07:24Z","timestamp":1576206444000},"page":"172849","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"special_numbering":"C","title":["Canstatin suppresses isoproterenol-induced cardiac hypertrophy through inhibition of calcineurin\/nuclear factor of activated T-cells pathway in rats"],"prefix":"10.1016","volume":"871","author":[{"given":"Akira","family":"Sugiyama","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muneyoshi","family":"Okada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideyuki","family":"Yamawaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2019.172849_bib1","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.jfda.2018.08.002","article-title":"Ubiquitin-protein ligase E3a (UBE3A) as a new biomarker of cardiac hypertrophy in cell models","volume":"27","author":"Cheng","year":"2019","journal-title":"J. Food Drug Anal."},{"key":"10.1016\/j.ejphar.2019.172849_bib2","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1161\/01.CIR.0000120390.68287.BB","article-title":"Hypertrophy of the heart A new therapeutic target?","volume":"109","author":"Frey","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.ejphar.2019.172849_bib3","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1038\/81321","article-title":"Decoding calcium signals involved in cardiac growth and function","volume":"6","author":"Frey","year":"2000","journal-title":"Nat. Med."},{"key":"10.1016\/j.ejphar.2019.172849_bib4","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1038\/351573a0","article-title":"Sympathetic regulation of cardiac calcium current is due exclusively to cAMP-dependent phosphorylation","volume":"351","author":"Hartzell","year":"1991","journal-title":"Nature"},{"key":"10.1016\/j.ejphar.2019.172849_bib5","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1016\/j.bbrc.2018.04.026","article-title":"Canstatin modulates L-type calcium channel activity in rat ventricular cardiomyocytes","volume":"499","author":"Imoto","year":"2018","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ejphar.2019.172849_bib6","doi-asserted-by":"crossref","first-page":"62","DOI":"10.3390\/ijms20010062","article-title":"Periostin mediates right ventricular failure through induction of inducible nitric oxide synthase expression in right ventricular fibroblasts from monocrotaline-induced pulmonary arterial hypertensive rats","volume":"20","author":"Imoto","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejphar.2019.172849_bib7","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1074\/jbc.275.2.1209","article-title":"Canstatin, a novel matrix-derived inhibitor of angiogenesis and tumor growth","volume":"275","author":"Kamphaus","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejphar.2019.172849_bib8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0173051","article-title":"Canstatin inhibits hypoxia-induced apoptosis through activation of integrin\/focal adhesion kinase\/Akt signaling pathway in H9c2 cardiomyoblasts","volume":"12","author":"Kanazawa","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.ejphar.2019.172849_bib9","doi-asserted-by":"crossref","first-page":"3114","DOI":"10.1172\/JCI27702","article-title":"TRPC6 fulfills a calcineurin signaling circuit during pathologic cardiac remodeling","volume":"116","author":"Kuwahara","year":"2006","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.ejphar.2019.172849_bib10","doi-asserted-by":"crossref","first-page":"H1340","DOI":"10.1152\/ajpheart.00592.2009","article-title":"NFATc4 is negatively regulated in miR-133a-mediated cardiomyocyte hypertrophic repression","volume":"298","author":"Li","year":"2010","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"10.1016\/j.ejphar.2019.172849_bib11","doi-asserted-by":"crossref","first-page":"4353","DOI":"10.1158\/0008-5472.CAN-04-3536","article-title":"Canstatin acts on endothelial and tumor cells via mitochondrial damage initiated through interaction with \u03b1v\u03b23 and \u03b1v\u03b25 integrins","volume":"65","author":"Magnon","year":"2005","journal-title":"Cancer Res."},{"key":"10.1016\/j.ejphar.2019.172849_bib12","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/S0092-8674(00)81573-1","article-title":"A calcineurin-dependent transcriptional pathway for cardiac hypertrophy","volume":"93","author":"Molkentin","year":"1998","journal-title":"Cell"},{"key":"10.1016\/j.ejphar.2019.172849_bib13","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1007\/s10495-016-1262-1","article-title":"Canstatin inhibits isoproterenol-induced apoptosis through preserving mitochondrial morphology in differentiated H9c2 cardiomyoblasts","volume":"21","author":"Okada","year":"2016","journal-title":"Apoptosis"},{"key":"10.1016\/j.ejphar.2019.172849_bib14","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1042\/cs0610265","article-title":"Cardiac sympathetic nerves as the final common pathway in the induction of adaptive cardiac hypertrophy","volume":"61","author":"\u00d6stman-Smith","year":"1981","journal-title":"Clin. Sci."},{"key":"10.1016\/j.ejphar.2019.172849_bib15","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1292\/jvms.17-0257","article-title":"Diverse distribution of tyrosine receptor kinase B isoforms in rat multiple tissues","volume":"79","author":"Otani","year":"2017","journal-title":"J. Vet. Med. Sci."},{"key":"10.1016\/j.ejphar.2019.172849_bib16","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/s11010-017-3253-0","article-title":"Apocynin prevents isoproterenol-induced cardiac hypertrophy in rat","volume":"445","author":"Saleem","year":"2018","journal-title":"Mol. Cell. Biochem."},{"key":"10.1016\/j.ejphar.2019.172849_bib17","doi-asserted-by":"crossref","first-page":"75","DOI":"10.12659\/MSMBR.900437","article-title":"Cardiac hypertrophy: an introduction to molecular and cellular basis","volume":"22","author":"Samak","year":"2016","journal-title":"Med. Sci. Monit. Basic Res."},{"key":"10.1016\/j.ejphar.2019.172849_bib18","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.yjmcc.2016.06.001","article-title":"Physiological and pathological cardiac hypertrophy","volume":"97","author":"Shimizu","year":"2016","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.ejphar.2019.172849_bib19","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1161\/01.RES.84.6.633","article-title":"Signaling in myocardial hypertrophy","volume":"84","author":"Sugden","year":"2012","journal-title":"Circ. Res."},{"key":"10.1016\/j.ejphar.2019.172849_bib20","doi-asserted-by":"crossref","first-page":"E741","DOI":"10.3390\/ijms19030741","article-title":"Endostatin stimulates proliferation and migration of myofibroblasts isolated from myocardial infarction model rats","volume":"19","author":"Sugiyama","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejphar.2019.172849_bib21","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1292\/jvms.18-0674","article-title":"Cathepsin S degrades arresten and canstatin in infarcted area after myocardial infarction in rats","author":"Sugiyama","year":"2019","journal-title":"J. Vet. Med. Sci."},{"key":"10.1016\/j.ejphar.2019.172849_bib22","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.ejphar.2017.04.027","article-title":"Pathophysiological roles of canstatin on myofibroblasts after myocardial infarction in rats","volume":"807","author":"Sugiyama","year":"2017","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2019.172849_bib23","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1093\/cvr\/cvs249","article-title":"\u03b2-Adrenergic receptor stimulation causes cardiac hypertrophy via a G\u03b2\u03b3\/Erk-dependent pathway","volume":"96","author":"Vidal","year":"2012","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.ejphar.2019.172849_bib24","doi-asserted-by":"crossref","first-page":"392","DOI":"10.3389\/fphar.2016.00392","article-title":"Hydrogen (H2) inhibits isoproterenol-induced cardiac hypertrophy via antioxidative pathways","volume":"7","author":"Zhang","year":"2016","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ejphar.2019.172849_bib25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/1755-5922.12241","article-title":"Protective effects of low-dose rosuvastatin on isoproterenol-induced chronic heart failure in rats by regulation of DDAH-ADMA-NO pathway","volume":"35","author":"Zhou","year":"2017","journal-title":"Cardiovasc. Ther."},{"key":"10.1016\/j.ejphar.2019.172849_bib26","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1161\/hc2601.090987","article-title":"Isoproterenol activates extracellular signal \u2013 regulated protein kinases in cardiomyocytes through calcineuin","volume":"104","author":"Zou","year":"2001","journal-title":"Circulation"}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299919308015?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299919308015?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,15]],"date-time":"2025-09-15T22:33:48Z","timestamp":1757975628000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299919308015"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3]]},"references-count":26,"alternative-id":["S0014299919308015"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2019.172849","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2020,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Canstatin suppresses isoproterenol-induced cardiac hypertrophy through inhibition of calcineurin\/nuclear factor of activated T-cells pathway in rats","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2019.172849","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"172849"}}